Bláha, Vladimír <br/><br/>
[The role of PCSK9-inhibitors and of lipoprotein apheresis in the treatment of homozygous and severe heterozygous familial hypercholesterolemia: A rivalry, or are things quite different?]  [electronic resource] 

 -  Vnitrni lekarstvi   
 - 43-50 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0042-773X 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal<br/>Anticholesteremic Agents--therapeutic use<br/>Blood Component Removal<br/>Cholesterol, LDL<br/>Humans<br/>Hypercholesterolemia<br/>Hyperlipoproteinemia Type II--drug therapy<br/>Lipoproteins<br/>PCSK9 Inhibitors<br/>Proprotein Convertase 9